Short CV/Education and training

  • 1980
    Undergraduate degree in veterinary medicine at the University of Veterinary Medicine, Hannover and LMU Munich, Germany

  • 1980 – 1981
    Clinical research assistant in veterinary obstetrics and gynaecology at LMU Munich

  • 1981
    Doctorate in veterinary medicine from LMU Munich

  • 1982 – 1984
    Research associate at the Max Planck Institute of Psychiatry, Munich

  • 1984 – 1986
    Research associate at the Outpatient Clinic for Internal Medicine, LMU Munich

  • 1987 – 1988
    Specialist training at the Neurological Clinic, LMU Munich

  • 1987
    Undergraduate degree in human medicine at LMU Munich

  • 1989
    Doctorate in human medicine at LMU Munich

  • 1989 – 1992
    Postdoctoral Fellow at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, MD, USA

  • 1992 – 1995
    Specialist training in neurology and psychiatry at the University of Göttingen, Germany

  • 1994
    Habilitation (postdoctoral qualification) in neuroendocrinology, neurology and psychiatry at the University of Göttingen

  • Since 1995
    Specialist in neurology and psychiatry, Göttingen

  • Since 1995
    Director of Clinical Neuroscience at the Max Planck Institute of Experimental Medicine, Göttingen

  • 1998
    Professor of psychiatry and neurology at the University of Göttingen

  • 2004
    Board certification in psychotherapy

  • 2008
    Additional honorary professorship in the Faculty of Biology, University of Göttingen

Selected publications

  • Ehrenreich H, Mitjans M, Van der Auwera S, Centeno TP, Begemann M, Grabe HJ, Bonn S, Nave KA (2016): OTTO: A new strategy to extract mental disease-relevant combinations of GWAS hits from individuals; Mol Psychiatry, doi: 10.1038/mp.2016.208.

  • Castillo-Gomez E, Oliveira B, Tapken D, Bertrand S, Klein-Schmidt C, Pan H, Zafeiriou P, Steiner J, Jurek B, Trippe R, Prüss H, Zimmermann W-H, Bertrand D, Hollmann M, Ehrenreich H: (2016) All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class. Mol Psychiatry, doi: 10.1038/mp.2016.125.

  • Hassouna I, Ott C, Dahm L, Offen N, Neher RA, Mitkovski M, Winkler D, Sperling S, Fries L, Goebbels S, Vreja IC, Hagemeyer N, Dittrich M, Rossetti MF, Kröhnert K, Hannke K, Boretius S, Zeug A, Höschen C, Dandekar T, Dere E, Neher E, Rizzoli SO, Nave KA, Sirén AL, Ehrenreich H. (2016) Revisiting adult neurogenesis and the role of erythropoietin for neuronal and oligodendroglial differentiation in the hippocampus. Mol Psychiatry, doi: 10.1038/mp.2015.212

  • Castillo-Gomez E, Kästner A, Steiner J, Schneider A, Hettling B, Poggi G, Ostehr K, Uhr M, Asif AR, Matzke M, Schmidt U5, Pfander V1, Hammer C, Schulz TF, Binder L, Stöcker W, Weber F, Ehrenreich H (2016) The brain as ′immunoprecipitator′ of serum autoantibodies against NMDAR1. Annals of Neurology 79(1):144-51. doi: 10.1002/ana.24545.

  • Stepniak B, Kästner A, Poggi G, Mitjans M, Begemann M, Hartmann A, Van der Auwera S, Sananbenesi F, Krueger-Burg D, Matuszko G, Brosi C, Homuth G, Völzke H, Benseler F, Bagni C, Fischer U, Dityatev A, Grabe HJ, Rujescu D, Fischer A, Ehrenreich H (2015) Accumulated common variants in the broader fragile X gene family modulate autistic phenotypes. EMBO Mol Med 7(12):1565-79

  • Dahm L, Ott C, Steiner J, Stepniak B, Teegen B, Saschenbrecker S, Hammer C, Borowski K, Begemann M, Lemke S, Rentzsch K, Probst C, Martens H, Wienands J, Spalletta G, Weissenborn K, Stöcker W, Ehrenreich H (2014) Seroprevalence of autoantibodies against brain antigens in health and disease. Annals of Neurology; 76(1):82-94. doi: 10.1002/ana.24189.

  • Stepniak B, Papiol S, Hammer C, Ramin A, Everts S, Hennig L, Begemann M, Ehrenreich H. (2014) Accumulated environmental risk determining age at schizophrenia onset, Lancet Psychiatry, published online Oct. 22, 2014

  • Hammer C, Stepniak B, Schneider A, Papiol S, Tantra M, Begemann M, Sirén AL, Pardo LA, Sperling S, Mohd Jofrry S, Gurvich A, Jensen N, Ostmeier K, Lühder F, Probst C, Martens H, Gillis M, Saher G, Assogna F, Spalletta G, Stöcker W, Schulz TF, Nave KA, Ehrenreich H. (2013) Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Mol Psychiatry 10: 1143-49

  • Hagemeyer N, Goebbels S, Papiol S, Kästner A, Hofer S, Begemann M, Gerwig UC, Boretius S, Wieser GL, Ronnenberg A, Gurvich A, Heckers SH, Frahm J, Nave KA, Ehrenreich H (2012) A myelin gene causative of a catatonia-depression syndrome upon aging. EMBO Mol Med 4:528-39

  • Wüstenberg T, Begemann M, Bartels C, Gefeller O, Stawicki S, Hinze-Selch D, Mohr A, Falkai P, Aldenhoff JB, Knauth M, Nave KA, Ehrenreich H (2011) Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. Mol Psychiatry 16: 26-36.

Membership in scientific bodies/juries

  • Member of the German Academy of Sciences Leopoldina

  • Member of the scientific advisory board for the German Primate Centre, since 2010

  • Member of the university council of the Hannover Medical School, since 2003

  • Membership in various American advisory boards on neuroprotection and neuroregeneration, since 2002

  • Vice president of the University of Göttingen, Germany, 2000 – 2002

Media coverage


You can only see the contact information of the academics in the database if you are a registered user of AcademiaNet.
Please register here


  1. Read what our members say about AcademiaNet.

No more excuses!

  1. Please download the brochure "No more excuses" and read more about female experts in Europe, and about AcademiaNet.

Similar profiles

  1. Prof. Dr. Wiebke Arlt


  2. Dr. Irene Agyepong

    HealthPublic Health

  3. Prof. Dr. Silvia Arber

    Biological and related sciences , HealthNeuroscience

  4. Prof. Dr. Heike Allgayer

    Biological and related sciences , Health



  1. "A ticking time bomb"

    In ten percent of all tested individuals, scientists of the Max Planck Institute of Experimental Medicine and colleagues find autoantibodies which can cause neuropsychiatric dysfunctions.